financetom
Business
financetom
/
Business
/
BlueScope spurns $10.7 billion offer, but leaves door open to talks
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BlueScope spurns $10.7 billion offer, but leaves door open to talks
Mar 11, 2026 5:39 AM

SYDNEY, Feb 26 (Reuters) - Australia's BlueScope Steel ( BLSFF ) rejected a A$15 billion ($10.7 billion) revised bid from SGH and U.S.-based Steel Dynamics ( STLD ), sending its shares down almost 5% on Thursday, but said it was open to further talks.

BlueScope's board said it was willing to engage with the consortium on a bid that reflects "the fair value of BlueScope", compared with the revised A$34 per share offer, pressing for a better understanding of how its North American assets would be valued.

"The offer price is not sufficient for the board to recommend a scheme of arrangement to its shareholders," the takeover target said.

The bid's value is reduced to A$32.35, following a A$1 special dividend declared in January and BlueScope's A$0.65 per share interim dividend. BlueScope has said it intends to distribute a further A$1.35 per share to investors in 2026.

BlueScope has now knocked back five takeover attempts from Steel Dynamics ( STLD ), including two joint bids made alongside SGH.

BlueScope shares fell as much as 4.9% on Thursday, before recovering some ground to close 2.33% lower. The benchmark S&P/ASX200 closed 0.51% higher.

"It's obviously negative in the short-term, there's no doubt about that. But BlueScope continues to have good operations and we're confident the price can materially increase over the medium-term," said Jamie Hannah, deputy head of investments at VanEck, a BlueScope and SGH investor.

"As shareholders in the company, we're not dissatisfied with them pushing for a higher price. BlueScope knows their long-term plans better than anybody else."

SGH declined to comment on BlueScope's statement. Steel Dynamics ( STLD ) did not immediately respond to Reuters' request for comment. 

A letter sent to SGH and Steel Dynamics ( STLD ) from BlueScope chair Jane McAloon, published on the ASX, said the steel producer was willing to engage with the consortium if certain conditions were met.

McAloon said BlueScope needed to better understand the valuation that would be put on the company's North American assets given that business would be sold to Steel Dynamics ( STLD ) as part of the process.

She added BlueScope was not willing to meet the consortium's proposal that the board needed to recommend the offer to investors before SGH and Steel Dynamics ( STLD ) carried out due diligence on its target. The letter also asked for more details on the funding structure that would be used in the takeover.

"If you are able to address the matters we have raised in this letter including, importantly, increasing the value of your proposal for all BlueScope shareholders, the board is open to further engagement with you, including providing some due diligence information," McAloon said.

Greg Cassidy, a senior analyst at Milford Asset Management, a BlueScope investor, said he believed a deal could still be done as BlueScope's directors "haven't outright said no" to SGH and Steel Dynamics ( STLD ).

"BlueScope have given them a potential opportunity to say, 'Okay, well, let's chat about how you've come up with this price and we can work out some differences.'"

($1 = 1.4037 Australian dollars)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Chemomab Therapeutics Reports Positive Data on Liver Disease Treatment
Chemomab Therapeutics Reports Positive Data on Liver Disease Treatment
May 25, 2025
01:17 PM EDT, 04/28/2025 (MT Newswires) -- Chemomab Therapeutics ( CMMB ) reported positive results from a Phase 2 trial of nebokitug, a treatment for primary sclerosing cholangitis and other fibro-inflammatory diseases. Patients treated with nebokitug exhibited significant changes in several proteins associated with fibrosis, inflammation and immune system activity with the effects increasing at higher doses, the company said...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Update: InMode Q1 Adjusted Earnings, Revenue Fall; Shares Drop
Update: InMode Q1 Adjusted Earnings, Revenue Fall; Shares Drop
May 25, 2025
01:23 PM EDT, 04/28/2025 (MT Newswires) -- (Updates with the latest stock price movement in the headline and the first paragraph.) InMode ( INMD ) shares were down more than 11% in recent trading Monday after the company reported lower quarterly earnings and cut its full-year adjusted earnings per share forecast. The company reported earlier Q1 non-GAAP earnings of $0.31...
James Hardie to Supply Siding, Trim Products to Daiwa House for Home Construction
James Hardie to Supply Siding, Trim Products to Daiwa House for Home Construction
May 25, 2025
01:22 PM EDT, 04/28/2025 (MT Newswires) -- James Hardie Industries ( JHX ) on Monday said it agreed to supply its Hardie siding and trim products to Daiwa House USA. Under the multi-year exclusive agreement, James Hardie's James Hardie Building Products unit will supply the products to Daiwa House's Stanley Martin Homes, CastleRock Communities, and Trumark Homes subsidiaries. The Daiwa...
Copyright 2023-2026 - www.financetom.com All Rights Reserved